239 related articles for article (PubMed ID: 12635138)
1. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
[TBL] [Abstract][Full Text] [Related]
3. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
J Clin Oncol; 2004 Apr; 22(7):1242-52. PubMed ID: 15051772
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer.
Nakopoulou L; Zervas A; Gakiopoulou-Givalou H; Constantinides C; Doumanis G; Davaris P; Dimopoulos C
Anticancer Res; 2000; 20(6B):4571-8. PubMed ID: 11205306
[TBL] [Abstract][Full Text] [Related]
6. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
7. The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.
Dillon DA; D'Aquila T; Reynolds AB; Fearon ER; Rimm DL
Am J Pathol; 1998 Jan; 152(1):75-82. PubMed ID: 9422525
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
9. Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer.
Miyamoto S; Baba H; Kuroda S; Kaibuchi K; Fukuda T; Maehara Y; Saito T
Br J Cancer; 2000 Nov; 83(9):1168-75. PubMed ID: 11027430
[TBL] [Abstract][Full Text] [Related]
10. Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.
Ashihara K; Saito T; Mizumoto H; Nishimura M; Tanaka R; Kudo R
Med Electron Microsc; 2002 Mar; 35(1):9-15. PubMed ID: 12111402
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between p120ctn translocation and malignant features of hepatocellular carcinoma].
Huang HY; Nong CZ; He WS; Guo LX; Nong SY; Pan LL; Zha XL
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):398-402. PubMed ID: 15355642
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection.
Shun CT; Wu MS; Lin MT; Chang MC; Lin JT; Chuang SM
Oncology; 2001; 60(4):339-45. PubMed ID: 11408802
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Saegusa M; Hamano M; Kuwata T; Yoshida T; Hashimura M; Akino F; Watanabe J; Kuramoto H; Okayasu I
Cancer Sci; 2003 Jan; 94(1):103-11. PubMed ID: 12708483
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.
Valizadeh A; Karayiannakis AJ; el-Hariry I; Kmiot W; Pignatelli M
Am J Pathol; 1997 Jun; 150(6):1977-84. PubMed ID: 9176391
[TBL] [Abstract][Full Text] [Related]
17. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Winn-Deen E; Oliver J; Fisher HA; Kaufman RP; Ross JS
Cancer; 2001 Dec; 92(11):2786-95. PubMed ID: 11753952
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
20. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines.
Husmark J; Heldin NE; Nilsson M
Int J Cancer; 1999 Nov; 83(5):692-9. PubMed ID: 10521809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
